Acquisition - July 31, 2014
Meda acquires Rottapharm
Meda has entered into a definitive agreement to acquire Italian firm Rottapharm for a consideration of SEK 21.2 billion. The consideration will comprise SEK 15.3 billion (€1.643 billion) in cash, 30 million Meda shares corresponding to a value of SEK 3.3 billion (€357 million) and a non-contingent deferred payment in January 2017 of SEK 2.6 billion […]
Acquisition - September 2, 2013
Meda acquires US respiratory company
Swedish Meda has signed an agreement to acquire the US development company Acton Pharmaceuticals, Inc. The agreement also includes the proprietary product Aerospan, an inhaler for the treatment of asthma that contains the active substance Flunisolide and approved by the FDA. The launch of Aerospan is planned to the beginning of 2014. According to Meda, the total […]
